Skip to main content
Wacker Chemie AG logo

Wacker Chemie AG — Investor Relations & Filings

Ticker · WCH ISIN · DE000WCH8881 LEI · 0NURKC5Q3CJYZPPK5046 F Manufacturing
Open in API
Filings indexed 346 across all filing types
Latest filing 2019-10-24 Interim / Quarterly Rep…
Country DE Germany
Listing F WCH

About Wacker Chemie AG

https://www.wacker.com/cms/en-de/home/h…

Wacker Chemie AG is a technology-focused chemical and biotechnology company that develops and manufactures a wide range of specialty products for global markets. The company's core activities are centered on silicone and polymer chemistry, providing advanced solutions for various sectors, including construction additives. A significant part of its business is Wacker Biotech, which operates as a full-service contract development and manufacturing organization (CDMO). This division specializes in the microbial-based production of therapeutic proteins, plasmid DNA (pDNA), messenger ribonucleic acid (mRNA), live microbial products (LMPs), and vaccines for the pharmaceutical and life sciences industries.

Recent filings

Filing Released Lang Actions
Q3 statement / Q3 financial report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report' for the period 'Q3 January through September 2019'. It contains comprehensive financial statements, including sales, EBITDA, EBIT, and financial position tables, as well as detailed management commentary on performance. It is clearly a full quarterly financial report rather than an announcement or summary. 9M 2019
2019-10-24 English
Wacker Chemie AG: WACKER Lowers Guidance for 2019
Earnings Release Classification · 100% confidence The document is a news release dated October 15, 2019, titled "Wacker Chemie AG: WACKER Lowers Guidance for 2019." It details changes to expected full-year financial performance indicators (sales, EBITDA, net income, net cash flow) compared to previous guidance. It also mentions preliminary unaudited figures for Q3 2019 and explicitly states that WACKER will publish its full 'interim report for Q3 2019' on October 24, 2019. Since this document is an announcement of preliminary results and a change in financial outlook, it aligns best with the Earnings Release (ER) category, which covers the initial announcement of periodical financial results (key highlights only). It is not the comprehensive Interim Report (IR) itself, nor is it a full transcript (CT) or a formal 10-K. The document is short enough (4801 chars) that if it were only announcing the release of a report, it might be RPA, but here it contains the core financial guidance change and preliminary Q3 numbers, making ER the most appropriate classification. Q3 2019
2019-10-15 English
Wacker Chemie AG: WACKER Lowers Guidance for 2019
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc' announcement dated October 15, 2019, explicitly titled 'Wacker Chemie AG: WACKER Lowers Guidance for 2019'. It discloses insider information according to Article 17 of MAR (Market Abuse Regulation) and details changes to the full-year financial forecast (sales, EBITDA, net income). This type of announcement, which provides key financial updates outside of a scheduled earnings release or comprehensive report, fits best under the 'Earnings Release' (ER) category, as it communicates preliminary or revised financial performance expectations. Although it mentions the Q3 2019 interim report will be published later, this document itself is the guidance revision, not the report announcement (RPA) or the full report (IR). It is a direct communication of financial performance expectations/changes. Q3 2019
2019-10-15 English
Wacker Chemie AG: WACKER Acquires a Stake in UK Battery Materials Specialist Nexeon
M&A Activity Classification · 99% confidence The document is a news release dated September 12, 2019, announcing that Wacker Chemie AG is acquiring a 25 percent stake in Nexeon Ltd., a UK battery materials specialist. The content focuses on a strategic investment and partnership, using keywords like 'Investment', 'acquires a stake', and detailing the strategic rationale. This type of announcement, detailing corporate actions like acquisitions or significant investments that affect the company's structure or strategy, fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if it were a mandatory disclosure without a better fit. However, since it details a specific financing/investment activity (acquiring a stake), 'CAP' is the most specific fit among the provided options, as it relates to capital structure changes or fundraising activities, even if it's an acquisition of equity in another entity. Reviewing the definitions: - CAP (Capital/Financing Update): Updates on company fundraising, financing activities, or capital structure changes. An acquisition of a 25% stake is a significant financing/investment activity. - RNS (Regulatory Filings): General regulatory announcements and fallback. This is too specific for the fallback. - TAR (M&A Activity): Announcements and documents related to merger proposals or takeover bids. This is an investment/stake acquisition, not a full merger or takeover bid, making CAP a slightly better fit for a minority stake purchase announcement. Therefore, CAP is the most appropriate classification for a strategic investment announcement.
2019-09-12 English
Wacker Chemie AG: Solid Chemical Business and a Challenging Solar Market Shape WACKER's Q2 Sales and Earnings
Earnings Release Classification · 100% confidence The document is titled 'Wacker Chemie AG: Solid Chemical Business and a Challenging Solar Market Shape WACKER’s Q2 Sales and Earnings' and explicitly states it relates to 'Quarterly / Interim Statement/9 Month figures'. It provides detailed financial metrics (Sales, EBITDA, Net Income, Cash Flow) specifically for 'Q2 2019' and compares them year-over-year and quarter-over-quarter. This structure is characteristic of a periodic financial report covering a period shorter than a full year. The presence of the term 'Interim Statement' and the focus on Q2 results strongly points towards an Interim/Quarterly Report. It is not a full Annual Report (10-K), an Earnings Release (ER, which is usually just the highlights), or a Call Transcript (CT). Therefore, the classification is Interim / Quarterly Report (IR). Q2 2019
2019-08-01 English
Datum:01.08.2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenbericht' (Interim Report) for Wacker Chemie AG covering the period from January to June 2019. It contains detailed financial statements, management commentary, and performance analysis for the second quarter and the first half of the year. It is not an announcement of a report, but the report itself, containing substantive financial data and tables. H1 2019
2019-08-01 German

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.